Specific antibodies modulate the interactions of adenovirus type 5 with dendritic cells  by Mercier, S et al.
www.elsevier.com/locate/yviro
Virology 322 (2004) 308–317Specific antibodies modulate the interactions of adenovirus type 5
with dendritic cells
S. Mercier,a H. Rouard,b M.H. Delfau-Larue,b and M. Eloita,*
aUMR INRA-AFSSA-ENVA 1161, Virologie, Ecole Nationale Ve´te´rinaire d’Alfort, 94704 Maisons-Afort Cedex, France
bLaboratoire d’Immunologie, Hoˆpital Henri-Mondor Assistance Publique-Hoˆpitaux de Paris, EA 2348 Universite´ Paris XII; Cre´teil, FranceReceived 13 August 2003; returned to author for revision 10 December 2003; accepted 27 January 2004Abstract
Adenovirus type 5 (Ad5) is able to induce an efficient CD8+ T lymphocyte (CTL) response against a transgene product, a property
thought to be linked to its ability to transduce dendritic cells (DCs). Little, however, is known about the capacity of Ad5 to interact with DCs
in the presence of specific antibodies, although most people test positive for antibodies directed against Ad5. In the present study, we found
that in the presence of Ad5 antibodies, a large fraction of Ad5 binds very efficiently to DCs, and that this binding is FcgRII/FcgRIII
dependent. Nevertheless, in the presence of high levels of antibodies against the whole virion, Ad5 entry was inhibited. Increased binding led
to increased entry in DCs in the presence of fiber-specific antibodies or in the presence of low amounts of a whole antiserum raised against
whole virions, showing that the relative concentration of antibodies directed against fiber and penton base plays a major role in entry efficacy.
Nevertheless, mice previously immunized with virions or purified fiber developed a lower transgene-specific CD8+ T cell response than
naive mice, although their serum appeared to increase virus entry into DCs in vitro.
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Gene transfer with adenovirus vectors (Ads) has been
used for the development of vaccines against infectious
diseases and cancers with some success in animal models
(Klonjkowski et al., 1999). Induction of cytotoxic CD8+ T
lymphocytes (CTL) is essential to obtain effective immunity
against various viral infections and tumors. There are now
several lines of evidence indicating that the efficiency of
Ads in eliciting CD8+ T cell responses is linked to their
capacity to transduce dendritic cells (DCs) following in vivo
administration (Jooss et al., 1998). DCs are the most potent
antigen-presenting cells (APC) with the unique ability for
inducing primary and secondary immune responses (Ban-
chereau et al., 2000). Immature DCs are in most peripheral
tissues where they capture and process native protein anti-
gens (Ag) through both the class I and II major histocom-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: meloit@vet-alfort.fr (M. Eloit).patibility pathways (MHC). In response to natural stimuli
(pathogens, inflammatory cytokines, necrotic cell frag-
ments, and CD40 cross-linking), DCs mature and can
migrate to T cell-rich areas of secondary lymphoid organs
where they display MHC-peptide complexes together with
co-stimulatory molecules (Hartmann et al., 1999). This
results in the activation of naive and resting T cells. Many
studies have demonstrated the ability of modified DCs to
present a large range of foreign antigens and have led to a
great interest in the use of DCs in vaccination against
pathogens and tumors. Gene transfer strategies have shown
that recombinant human type 5 Ad (Ad5) is one of the most
effective vehicles for transducing DCs in vitro (Tillman et
al., 1999). Moreover, transduction of DCs by Ads allows
persistence of Ag presentation over time and induces partial
maturation of DCs, leading to an increase in the immunos-
timulatory function of these APC (Morelli et al., 2000).
Nevertheless, there is a paradox between these observa-
tions and the fact that transduction of DCs requires high
multiplicities of infection (MOI) (Dietz and Vuk-Pavlovic,
1998), which are unlikely to occur in vivo. In particular, the
mature DCs are less permissive to Ad5 transduction than
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mice, in which most of the vaccine and immunotherapy
trials have been conducted. Some molecular aspects of these
features have now been elucidated. Both immature and
mature DCs do not express the coxsackie and Ad receptor
(CAR), which serves as a high Ads affinity receptor for the
Ad fiber capsid protein and allows attachment of group C
Ads (Ad2 and Ad5) to the majority of permissive human
cell types (Bergelson et al., 1997; Linette et al., 2000). MHC
I molecules may also serve as receptors for the fiber protein
(Hong et al., 1997). Alternatively, attachment of Ad5 to
cells of hematopoietic origin may occur upon binding of the
penton base capsid protein to the integrin amh2 (Huang et
al., 1996). However, despite the expression of large amounts
of MHC I and amh2 by DCs, these alternative receptors do
not appear to compensate efficiently for the lack of CAR.
For internalization in permissive cell lines, Ad5 requires an
additional interaction between the Arg-Gly-Asp (RGD)
motif on the penton base and avh3, avh5, or avh1
integrins on the cell surface (Li et al., 2001; Wickham et
al., 1993). DCs express low levels of avh3, and the
maturation-induced downregulation of avh5 is in accor-
dance with the low susceptibility of DCs to Ad5 transduc-
tion (Rea et al., 1999).
On the other hand, little is known about the ability of Ad
to interact with DCs in vivo, and more particularly, how the
components of the plasma or the intercellular fluid environ-Fig. 1. Binding of fiber and penton base to A549 cells and DCs. For each binding a
1 h at 4 jC. The protein binding efficiency was evaluated by flow cytometry after c
penton-base (1D2).ment, notably immunoglobulins (Ig) directed against Ad,
may interfere in this interaction. This information is crucial
for in vivo trials using Ads for vaccination or gene therapy
purposes. Indeed, most people test positive for Ad5/2-
specific antibodies, the two Ads most thoroughly studied
and most frequently used for in vivo gene transfer experi-
ments. Therefore, it was of considerable interest to study
whether a preexisting immunity against Ad may influence
the interaction between DCs and the Ad, and whether this
immunity may modify the CD8+ T cell response against the
transgene product. A histological study in monkeys sug-
gested that a preexisting immunity against Ad5 could
enhance gene transfer into APCs by Fc receptor-mediated
internalization and the internalization of Ad associated with
Ig (immune complexes) (Varnavski et al., 2002). The
receptors for the Fc region of IgG (FcgRs) are a family of
membrane glycoproteins expressed on hematopoietic cells
(Ravetch and Bolland, 2001). Most FcgRs do not bind IgG
unless they are associated with antigens in the form of
immune complexes. Thus, FcgRII (CD32) and FcgRIII
(CD16) bind monomeric Ig quite inefficiently, but bind
immune complexes with very high affinity. Many studies
have shown that antigens associated with Ig to form immune
complexes could be internalized by DCs via the FcgRs, and
that the peptides so-derived could be presented by MHC I to
generate specific CTL (Amigorena, 2002). Also, Rafiq et al.
(2002) have shown that FcgR targeting of antigen conferredssay, 5  105 cells were incubated with 50 Ag/ml of recombinant protein for
ell labeling with a monoclonal antibody specific for the fiber (2B1.16) or the
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responses in vivo and to induce tumor immunity. Several
studies have suggested that the uptake of immune com-
plexes could supplement antigen presentation by several
orders of magnitude compared with pinocytosis of soluble
antigens. Moreover, immune complexes induce maturation
of murine DCs after binding to FcgRIII (Regnault et al.,
1999). Nevertheless, the role of specific antibodies in Ad
entry and delivery to the nucleus allowing for gene expres-
sion remains to be elucidated.
To gain understanding of the interaction of Ad with DCs,
we first evaluated the binding of some of the proteins of the
adenoviral capsid (fiber, penton) to DCs. We next studied
the attachment of Ad5 to DCs under conditions resembling a
physiological context that is in the presence of a serum
containing or not antibodies against Ad5 or the fiber.Fig. 2. Ad5 binding to DCs and A549 cells in the presence of pre-immune (A) or an
 109 fluorescent adenoviral particles previously incubated with serum. Speci
represented in black, control cells in white. FACS analysis of Ad5 binding on D
blocking of FcgRII and FcgRIII (CD32 and CD16) with specific monoclonal antFinally, we investigated the influence of a preexisting
immunity against Ad5 or against the fiber protein on the
induction of a CD8+ T cell immune response against the
transgene product after intramuscular inoculation of mice
with a recombinant Ad5.Results
Attachment of the fiber and the penton base to dendritic
cells
We first compared the binding ability of two adenoviral
capsid proteins the fiber and the penton base to DCs and
A549 cells. A549 cells express the high Ads affinity
receptor for the Ad5 fiber capsid protein CAR and areti-Ad immune sera (B). For each assay, 5  105 cells were incubated with 5
fic Ad5 binding was evaluated by flow cytometry. Ad-treated cells are
Cs after pre-incubation with anti-Ad5 immune serum without (C) or with
ibodies (D).
Fig. 3. Transduction of DCs with Ad5GFP previously incubated with an
anti-virion serum undiluted or diluted 10- and 100-fold. The percentage of
GFP-expressing cells was detected by FACS 24 h after transduction (A).
Fluorescence intensity of transduced cells (B).
Fig. 4. Transduction of DCs with Ad5GFP previously incubated with an
anti-fiber serum undiluted or diluted 10- and 100-fold. The percentage of
GFP-expressing cells was detected by FACS 24 h after transduction (A).
Fluorescence intensity of transduced cells (B).
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cells were incubated with each of the two recombinant
proteins at 4 jC. The attachment was evaluated by flow
cytometry after cell labeling with monoclonal antibodies
specific for the fiber or the penton base. The results shown
in Fig. 1 revealed that the fiber and the penton base bound
efficiently to A549 cells, whereas only the penton base
bound efficiently to DCs. The specificity of this binding was
confirmed because (i) no cell labeling was evidenced when
extracts of SF9 cells infected with a nonrelevant baculovirus
were used (ii) by the implication of the RGD sequence, as
this binding was diminished when we used a recombinant
penton base protein carrying a mutation in this RGD motif
(Fig. 1). In these assays, no or very little attachment of the
recombinant fiber protein to DCs could be detected.
Ad5-specific antibodies target Ad5 binding to the FccR on
dendritic cells
To characterize the interaction that occurs in vivo be-
tween the Ad5 and the DCs, the binding ability of Ad5 on
DCs was evaluated in the presence of pre-immune or
immune sera so as to mimic contact in a physiological
environment. For this purpose, we used a fluorescent Ad5
obtained after the covalent binding of a fluorochrome
(Alexa Fluor 488) to the capsid proteins of the virus. First,
DCs were incubated at 4 jC with the fluorescent Ad5,
which had been previously incubated with a pre-immuneserum at 37 jC. The attachment was evaluated by flow
cytometry. The results presented in Fig. 2A showed that the
binding of Ad5 to DCs was poor compared with its binding
to A549 cells.
To examine the influence of anti-Ad5 antibodies on the
interaction between Ad5 and DCs, binding of fluorescent
Ad5 to DCs was evaluated at 4 jC after pre-incubation of
the viral particles with an antiserum directed against whole
virions. FACS analysis showed that the attachment of Ad5
to DCs was strongly increased on a fraction of cells in the
presence of this immune serum, whereas under the same
conditions, the attachment to A549 was totally inhibited
(Fig. 2B). We observed that the attachment of the fluores-
cent Ad5 was also increased in the presence of an anti-fiber
antiserum (data not shown).
We hypothesized that the FcgRII and FcgRIII (CD16 and
CD32) expressed by the DCs (data not shown) might be
implicated in the enhancement of Ad5 attachment obtained in
the presence of the immune sera. To test this hypothesis, we
pre-incubated the DCs with blocking antibodies against
FcgRII (Mab IV.3) and FcgRIII (Mab 3G8) before adding
the mixture of immune serum and fluorescent Ad5. We then
evaluated the attachment by measuring the intensity of
fluorescence associated with the cells by FACS analysis.
Under these conditions, we observed amarked decrease in the
‘‘hyper-attachment’’ (Fig. 2D) compared with the control
sample in which the FcgRswere not blocked (Fig. 2C). These
results demonstrated that, in the presence of Ad5 antibodies,
the Ad5 was associated in immune complexes and that viral
binding became targeted to FcgRs expressed on DCs.
nization protocol.
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transduction as a function of the specificity of the antibodies
To evaluate the ability of Ad5 immune complexes bound
to FcgRs to be internalized and allow the expression of the
transgene in DCs, transduction experiments were performed
with an Ad5 encoding the green fluorescent protein
(Ad5GFP), whose expression could be easily detected by
flow cytometry. The cells were incubated at 37 jC with a
mixture of Ad5GFP and an anti-virion serum containing a
high Ad5 antibody titer (>8000), as determined by seroneu-
tralization. The viral mixture was removed and the cells
were incubated for 24 h at 37 jC. Using flow cytometry
analysis, we observed in each transduction assay that the
presence of anti-Ad5 antibodies strongly reduced the per-
centage of transduced DCs in a dose-dependent manner
(Fig. 3A). We observed a total inhibition in transduction of
DCs when an anti-virion serum was mixed with the virus in
comparison with the percentage of transduced DCs obtained
after incubation of the Ad5GFP with a pre-immune serum.
Nevertheless, the pre-incubation of the Ad5GFP with im-
mune sera containing smaller concentrations of anti-Ad5
antibodies (corresponding to the same serum serially diluted
10 to 100-fold) allowed a 4-fold increase in GFP expression
in the fraction of transduced DCs compared with the virus
incubated with a pre-immune serum (Fig. 3B). It seems,
therefore, that at low concentrations of anti-virion anti-
bodies, only a fraction of the DC population bound immune
complexes and was very efficiently transduced while the
Fig. 5. ImmuFig. 6. Specific anti-hGal IFN-g-secreting cells detected after Ad5hGal inoculatio
naive mice. The number of hGal peptide-specific CD8+ T cells was determined d
after Ad5hGal inoculation. Results are expressed as IFN-g SFC per 106 PBMCs a
the presence and absence of hGal peptide. Naive animals were used as negativeremaining cells were not susceptible to Ad5 targeted to
FcgRs. We therefore hypothesized that depending on the
relative amount of antibodies directed against different virus
proteins, the binding of the immune complexes to the FcgRs
might or might not be followed by an enhancement in virus
transduction. As we have previously shown that the fiber
does not bind to DCs and cannot participate in virus entry,
we did similar experiments using a fiber-specific polyclonal
antiserum so that this antiserum did not contain antibodies
directed against any other viral protein necessary for the
post-binding step(s) of virus entry. As shown in Fig. 4A, the
pre-incubation of the virus with anti-fiber antiserum did not
significantly affect the percentage of transduced DCs.
Moreover, the anti-fiber antiserum allowed a 3-fold en-
hancement in transduction of DCs compared with the
transduction of DCs in the presence of a pre-immune serum
(Fig. 4B). Therefore, binding to the FcgRs could mediate
internalization of immune complexes through a pathway
that led to transgene expression, under the condition that the
interactions of viral proteins other than the fiber with cell
receptors were not blocked.
Preexisting immunity to adenovirus inhibits the induction of
the CD8+ T cell immune response against the transgene
product
It is well known that neutralizing antibodies inhibit the
immune response against the transgene product. But the
specific mechanisms of this inhibition are not clear. In ann in mice pre-immunized either with the fiber protein or an Ad5null or in
irectly ex vivo by an IFN-g-specific ELISPOT assay at 10, 18, and 41 days
nd are calculated as the difference between the number of spots observed in
control.
Fig. 7. Neutralization index of sera from animals pre-immunized with an Ad5null or the recombinant fiber protein. Animals were bled at day 0, before the
inoculation of the Ad5hGal. The serum from naive animals was used as a negative control.
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Ad5 or anti-fiber immunity on the induction of a CD8+ Tcell
immune response against the transgene product expressed by
Ad5, mice were pre-immunized with either an Ad5null (an
Ad5 carrying no transgene) or with a recombinant fiber
protein according to the protocol presented in Fig. 5. Mice
were then inoculated intramuscularly with an Ad5 encoding
the h-Galactosidase protein (Ad5hGal). The CD8+ T im-
mune response against the hGal was evaluated 10, 18, and 41
days post Ad5hGal inoculation using anti-IFN-g ELISPOT
assays. As shown in Fig. 6, the CD8+ T cell response against
hGal detected in the animals pre-immunized with either
Ad5null or the fiber protein was lower than that detected in
naive animals that had not been pre-immunized. On the other
hand, the CD8+ Tcell immune response against the transgene
product detected in animals pre-immunized with the fiber
protein was at all times superior or equal to that observed in
mice pre-immunized with the Ad5null.Fig. 8. Transduction efficiency of DCs with an Ad5GFP pre-incubated with
serum from animals immunized with the Ad5null, the recombinant fiber
protein, or from naive animals. Fluorescence intensity of transduced cells
was detected by flow cytometry 24 h after transduction. Untransduced cells
were used as fluorescence negative control.To investigate the mechanisms underlying the phenom-
ena observed in vivo, sera from pre-immunized animals
were collected at day 0, just before the inoculation of
Ad5hgal, and were used for in vitro experiments assessing
neutralization, binding, and transduction. Seroneutralization
in HEK 293 cells allowed us to evaluate the inhibition of the
CAR-dependent transduction mediated by the sera at the
time of Ad5hgal inoculation. This assay showed that the
neutralization index of the serum collected from mice
immunized with fiber was 60 times higher than that of the
serum collected from mice immunized with Ad5null (Fig.
7). On the other hand, in transduction experiments, DCs
expressed higher levels of the transgene product after
incubation of the Ad5GFP with the anti-fiber serum than
after incubation with the anti-virion serum (Fig. 8).Discussion
Several studies suggest that transduction of DCs plays a
key role in eliciting a CD8+ T cell response against Ad5-
encoded proteins (Jooss et al., 1998; Mercier et al., 2002).
Nevertheless, despite the presence of antibodies directed
against Ad5 in a large percentage of the population (Chir-
mule et al., 1999), no study has analyzed the interactions of
Ad5 with DCs in the presence of Ad5-specific antibodies. In
fact, antibodies against Ad5 could theoretically modify the
transduction of DCs, either by blocking the virus entry as is
the case for most cells (Yang et al., 1996), or because
trapping of immune complexes by the FcgRs expressed
by DCs could facilitate post-binding events. Therefore, we
have designed a set of experiments aimed at addressing
these issues. We have found that in the presence of Ad5
antibodies, viral particles bound very efficiently to a fraction
of DCs, and that this binding was FcgRII/FcgRIII depen-
dent. Nevertheless, the expression of virus-encoded proteins
in DCs was strongly inhibited under these conditions. It
seems, therefore, that indirect binding of Ad5 to FcgRII/
FcgRIII was insufficient for virus entry by a pathway
S. Mercier et al. / Virology 322 (2004) 308–317314allowing gene expression in presence of anti-virions serum.
We reasoned that the entry could be inhibited for several
reasons. First, binding to FcgRs could decrease the efficien-
cy of the subsequent receptor-mediated endocytosis. Alter-
natively, the anti-virion serum could contain antibodies
specific for viral proteins implicated in entry. We have
shown that, by contrast to the fiber, the penton base binds
efficiently to DCs. Thus, antibodies against the penton base
could inhibit the transduction due to the role of this viral
capsid protein in integrin-mediated endocytosis. Also, anti-
bodies directed against the hexon and the penton base are
capable of intracellular neutralization by inhibiting the
release of Ad5 from endocytotic vesicles, thus suggesting
another possible mechanism of inhibition (Wohlfart, 1988;
Wohlfart et al., 1985). In fact, when only anti-fiber anti-
bodies were used, the increased binding led to a propor-
tional increase transduction of DCs. Notably, when a serum
containing only low amounts of Ad5 antibodies was used,
we also noted a strong increase in Ad5 entry. The most
probable explanation is that the residual levels of anti-fiber
antibodies were sufficient for Ad5 targeting to FcgRII/
FcgRIII, but that levels of anti-penton base or anti-hexon
antibodies were insufficient to block the post-binding step
events. Taken together, these results suggest that following
Ad5 inoculation in vivo, depending on the immune status of
the recipients and particularly the levels of circulating anti-
bodies and the relative concentration of anti-fiber and anti-
penton base-specific antibodies, Ad5-vectored gene transfer
into DCs can be substantially different than in naive
recipients, ranging from complete inhibition to an increase
in transgene expression.
To investigate whether these results were relevant in
vivo, we have inoculated an Ad5 encoding hgal protein in
mice that were previously immunized either with the fiber or
with an Ad5 not expressing the hgal gene and analyzed the
CD8+ T cell response against the hgal protein. This re-
sponse was strongly inhibited in Ad5- or fiber-immunized
mice compared with that of naive mice, despite that the
serum of immunized mice increased transgene delivery in
DCs in vitro (Fig. 8). Thus, in vivo, Ad5 targeting FcgRs of
DCs in fiber-immunized mice did not lead to an increase in
the CD8+ T cell response. Several explanations may ac-
count for this result. A preexisting Ad5 immunity in
monkeys has been associated with an increase in innate
immunity as measured by systemic concentration of IL-6
following readministration of Ad5 (Varnavski et al., 2002).
The Ad5 inoculum could also have been cleared by macro-
phages following opsonization of immune complexes.
Moreover, the interaction of immune complexes with
FcgRII/FcgRIII may have increased the production of IL-
8, TNF-a, and IFN-g by NK cells and led to a higher
inflammatory response resulting in a rapid clearance of the
Ad5 inoculum. Finally, pre-immunization of mice with the
fiber or whole particles should have generated specific anti-
Ad5 T cell responses that may have accelerated the clear-
ance of Ad5-hgal-transduced cells. Adoptive transfer ofspecific Ig into mice could have helped to address the role
of antibodies, but would have been far from the natural
conditions of previous Ad exposure of recipients, which
leads to an active immune response.
Under the conditions of immunization used, the serum
from the mice immunized with fiber was much more
efficient in neutralizing gene delivery through the CAR-
dependant pathway than the serum from mice immunized
with the whole virus. On the other hand, the serum from the
mice immunized with fiber was more efficient in promoting
Ad5-mediated gene delivery in DCs. As similar CD8+ T cell
responses against hgal were recorded following Adhgal
injection in both groups, this suggests that two pathways
of antigen presentation (direct transduction of CAR-express-
ing cells and cross-priming of DCs) can be followed with
comparable outcomes.
It is also noteworthy that the level of circulating neutral-
izing antibodies before Ad administration, which mainly
reflects the inhibition of the CAR-dependant pathway, did
not correlate with the inhibition in CD8+ T cell induction
against virus-encoded proteins. This should not be interpreted
as a demonstration of a lesser role of cross-priming from
CAR-expressing cells versus direct transduction of DCs
because we show here that sera with high neutralizing activity
can also be more efficient in facilitating gene delivery in DCs
through FcgR pathways. These results underscore that the
level of induction of CD8+ T cell responses directed against
transgene products in Ad5 immune recipients of Ad-mediat-
ed gene delivery is not readily predictable from the level of
preexisting Ad5 neutralizing antibodies, which has implica-
tions both for vaccination and gene therapy.Materials and methods
Cell lines and media
HEK 293 cells (Ad5-transformed human embryonic
kidney cells; Graham et al., 1977) and A549 cells (derived
from a human carcinoma of the lung) were obtained from
the American Type Culture Collection. Cells were grown at
37 jC with 5% CO2 in Dulbecco-Modified Eagle Medium
(Invitrogen, Cergy Pontoise, France) supplemented with
10% fetal calf serum (Invitrogen), penicillin (50 UI/ml)
streptomycin (50 Ag/ml), and sodium pyruvate (1 mM).
Differentiation of dendritic cells
Peripheral blood mononuclear cells were obtained by
leukapheresis from volunteers after approval by the local
ethical committee of Henri Mondor Hospital (Cre´teil,
France). Monocytes were isolated by counterflow centrifu-
gation. Immature DCs were differentiated from monocytes
in Lifecell culture bags (Nexell Therapeutics Inc., Irvine,
CA, USA) at 2  106 cells/ml for 6 days (Rouard et al.,
2000). Cultures were performed in AIM V glutamax medi-
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ml; Leucomax, Schering-Plough, Levallois Perret, France)
and IL-13 (50 ng/ml) kindly provided by Sanofi (Sanofi
Recherche, Labe`ge, France). Immature DCs were cryopre-
served in 4% human albumin (LFB, Courtaboeuf, France)
with 10% dimethylsuloxide.
Adenoviruses
The recombinant Ad5hGal and Ad5GFP were kindly
provided by B. Klonjkowski (National Veterinary School of
Alfort, Maisons-Alfort, France). These viruses are E1- and
E3-deleted Ads-based vectors. They carry the transgene in
the E1 region under the control of the cytomegalovirus
immediate early promoter. Ad vectors were amplified by
infection of HEK 293 cells and purified on cesium chloride
gradients. Viral titers were determined by end-point dilution
(TCID50) in HEK 293 cells and calculations were done
according to the method of Reed and Munch. Viral particle
concentration was determined by measuring the absorbance
at 260 nm (Sweeney and Hennessey, 2002). Viral stocks
were tested for the absence of replication-competent Ads
(RCA) (Dion et al., 1996).
Virus labeling
The suspension of Ad5 was desalted on a PD-10 column
(Pharmacia) equilibrated in phosphate-buffered saline
(PBS). The labeling was performed using the Alexa Fluor
488 Protein Labeling Kit (Molecular Probes) as indicated by
the manufacturer. Briefly, 500 Al of a viral suspension
containing 1012.4 viral particles/ml was added to the vial
of reactive dye. The reaction mixture was stirred for 1 h at
room temperature in the dark. Free dye was removed by
passing the viral solution through an exclusion column
furnished by the manufacturer. The concentration of fluo-
rescent virus was determined by spectrophotometry at 260
nm (Sweeney and Hennessey, 2002). Fluorescent virus was
aliquoted and stored at 20 jC until used.
Recombinant proteins and sera
Recombinant Autographa californica multiple nuclear
polyhedrosis virus (AcMNPV) expressing wild-type (wt)
Ad5 fiber (F5FL581), wt Ad2 penton base (Pb2FL571), and
a modified Ad2 penton base bearing a substitution in the
RGD motif (R340E) have been previously described (Hong
et al., 1999; Hong and Boulanger, 1995; Karayan et al.,
1994).
The antiserum directed against whole virions was col-
lected from mice immunized two times at a 6-week
interval by the intramuscular route with a 50-Al suspension
l suspension containing 109 TCID50 of Ad5 in PBS. The
anti-fiber serum was obtained from mice inoculated by the
intramuscular route with 10 Ag of recombinant Ad5 fiber
protein in complete Freund’s adjuvant followed by a boost2 weeks later with 10 Ag of Ad5 fiber protein in incom-
plete Freund adjuvant. For both sera, mice were bled 2
weeks after the second inoculation.
Fluorescent Ad5 binding
For each binding experiment 5 105 cells were used. The
cells were incubated with 109 particles of fluorescent Ad in a
total volume of 100 Al of PBS at 4 jC for 2 h. The cells were
then washed twice with 400 Al of PBS and finally suspended
in 400 Al of 1% paraformaldehyde in PBS. For binding
experiments in the presence of serum, 109 particles of
fluorescent Ad5 were mixed with 10 Al of serum (10% final)
and incubated for 1 h at 37 jC and then cooled on ice before
adding to the cells. For FcgR blocking, 40 Ag/ml of Mab IV.3
and Mab 3G8, specific for FcgRII and FcgRIII, respectively,
was incubated with the cells for 1 h at 4 jC. Cells were then
washed twice in PBS before incubation with the mixture of
virus and immune serum. The samples were kept on ice
throughout the experiment so as to maintain the temperature
V4 jC, making virus internalization very unlikely.
Recombinant viral protein binding
For each binding experiment, 106 cells were used. The
cells were incubated for 1 h at 4 jC in 100 Al of PBS with
lysate of insect cells containing recombinant fiber (F5FL581)
(50 Ag/ml), recombinant wt (Pb2FL571), or mutant penton
base (R340E) (50 Ag/ml). Negative control corresponds to
cells incubated with a control lysate. The cells were then
washed twice and protein attachment was detected using
Mabs 2B1.16 and 1D2 directed against the fiber protein and
the penton base protein, respectively (Hong et al., 2000). The
secondary PE-conjugated rabbit anti-mouse Ig antibodies
were purchased from Dako (Trappes, France). Cells were
fixed with 1% paraformaldehyde in PBS.
Transduction assays
Transduction assays were performed on 7.5  105 cells.
Gene transfer efficiency into DCs was determined using
Ad5GFP, whose expression could be easily detected by flow
cytometry. The virus was mixed with the serum for 1 h at 37
jC and cooled on ice before adding to the cells. The cells
were suspended in 250 Al of medium (AIM V glutamax
medium; Life Technologies) and incubated with Ad5GFP at
an MOI of 10. After 2 h at 4 jC, medium containing the
unbound virus was removed and replaced with 500 Al fresh
medium containing GM-CSF (500 UI/ml) and IL-4 (50 ng/
ml). Transduction efficiency was assessed 20–24 h later by
measuring GFP expression by flow cytometry.
Facs analysis
The samples were evaluated by a FACScan (Becton
Dickinson, Le Pont de Claix, France) flow cytometer. For
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data were analyzed with the LYSIS II software program
(Becton Dickinson).
Immunization with adenoviruses or recombinant fiber
protein and animal procedures
Female C57BL/6 mice, 7 weeks of age, were purchased
from Iffa Credo (L’Arbresle, France). Animals were handled
in accordance with the Institutional Guidelines of the
National Veterinary School of Alfort. Groups of seven mice
were injected by intramuscular route at one site of the
quadriceps with 100 Al of inoculum. For pre-immunization,
the inoculums were either 10 Ag of recombinant fiber
protein in complete Freund’s adjuvant (or incomplete
Freund’s adjuvant for the boost) or 108 TCID50 of Ad5null.
After pre-immunization, mice were inoculated by the intra-
muscular route with 108 TCID50 of Ad5hGal at one site of
the quadriceps with 50 Al of inoculum. Peripheral blood was
collected at the indicated time points. For all analyses, blood
samples were pooled from animals in the same group.
Determination of serum neutralization index
To determine the neutralization index of each serum, 10
Al of serum collected from mice was heat-inactivated for 30
min at 56 jC and incubated for 1 h at 37 jC with 10 Al of
Ad5. Ten microliters of this suspension was titrated by end
point dilution in HEK 293 cells. The titer of the suspension
was estimated after 7 days of incubation with cells and
compared with the titer measured for a viral suspension
mixed with a negative serum. The difference measured for
these two titers was defined as the neutralization index of
the serum.
Anti-IFN-c ELISPOT assay
The gamma interferon (IFN-g) ELISPOT assay was
performed as previously described (Mercier et al., 2002).
Briefly, 96-well nitrocellulose plates (Multiscreen HA,
Millipore corporation, Bedford, MA) were incubated O/N
at 4 jC with 40 ng of anti-mouse IFN-g MAb R4-6A2
(PharMingen, San Diego, CA)/well. Wells were washed
repeatedly with culture medium and saturated with complete
medium for 30 min at 37 jC. MHC I-compatible target
cells, RMA-S cells, were pulsed with a synthetic peptide (40
Ag/ml) representing the CD8+ epitope ICPMYARV (I8V) of
hGal in the H-2b haplotype. Serially diluted peripheral
blood mononuclear cells (PBMCs) (5  105 to 0.6  105)
were co-cultured with 105 RMA-S in the ELISPOTwells, in
medium supplemented with recombinant human interleukin
2 (30 UI/ml) (Roche Molecular Biochemicals), for 24 h at
37 jC under 5% CO2. After extensive washing with PBS–
0.05% Tween 20, plates were incubated O/N at 4 jC with 50
ng/well of biotinylated anti-mouse IFN-g Mab XMG1.2
(PharMingen) and then with ExtrAvidin alkaline phospha-tase conjugate (Sigma-Aldrich, St-Quentin Fallavier,
France) for 1 h at room temperature. Spots were developed
by adding an alkaline phosphatase conjugate substrate (Bio-
Rad Laboratories, Hercules, CA). The number of spots
corresponding to IFN-g-secreting cells was determined by
using a KS-ELISPOT (Zeiss-Kontron, Jena, Germany).Acknowledgments
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